ARCH Venture Partners IX, LLC - 10%+ Owner at Lyell Immunopharma, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
LYEL on Nasdaq
All Insider Reports
All Insider Reports

Sponsored

ARCH Venture Partners IX, LLC - trading volume in the past year for Lyell Immunopharma, Inc.

Holdings reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,426,528 $36,533,382 $25.61 06 Mar 2026 Indirect

Transactions reported by ARCH Venture Partners IX, LLC for Lyell Immunopharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.